Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 301 AL 315

An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure

Boopathi S, Poma AB, Garduño-Juárez R.

Int J Mol Sci. 2021 Oct 6;22(19):10798. doi: 10.3390/ijms221910798.

[Neuroprotective treatment of tauopathies]

Respondek G, Krey L, Huber M, Pflugrad H, Wegner F, Höglinger GU.

Nervenarzt. 2021 Dec;92(12):1227-1238. doi: 10.1007/s00115-021-01210-0. Epub 2021 Oct 15.

Aduhelm: The Best Hope for Alzheimer's Disease Patients or the Worst Decision the FDA Has Ever Made?

Kurkinen M, Tran L.

J Alzheimers Dis. 2021;84(3):969-971. doi: 10.3233/JAD-215105.

AD Hypotheses and Suggested Clinical Trials

Mandal PK, Samkaria A, Maroon JC.

ACS Chem Neurosci. 2021 Nov 3;12(21):3968-3971. doi: 10.1021/acschemneuro.1c00627. Epub 2021 Oct 18.

Ferulic Acid in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies

Wang EJ, Wu MY, Lu JH.

Cells. 2021 Oct 5;10(10):2653. doi: 10.3390/cells10102653.

A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials

Gonzales MM, Krishnamurthy S, Garbarino V, Daeihagh AS, Gillispie GJ, Deep G, Craft S, Orr ME.

Mech Ageing Dev. 2021 Dec;200:111589. doi: 10.1016/j.mad.2021.111589. Epub 2021 Oct 21.

FDA Drug Approval and the Ethics of Desperation

Largent EA, Peterson A, Lynch HF.

JAMA Intern Med. 2021 Dec 1;181(12):1555-1556. doi: 10.1001/jamainternmed.2021.6045.

A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer's Disease

Arora S, Sharma D, Layek B, Singh J.

Mol Pharm. 2021 Dec 6;18(12):4237-4255. doi: 10.1021/acs.molpharmaceut.1c00611. Epub 2021 Oct 27.

Genomics of Alzheimer's disease implicates the innate and adaptive immune systems

Li Y, Laws SM, Miles LA, Wiley JS, Huang X, Masters CL, Gu BJ.

Cell Mol Life Sci. 2021 Dec;78(23):7397-7426. doi: 10.1007/s00018-021-03986-5. Epub 2021 Oct 27.

Nanomaterials in Alzheimer's disease treatment: a comprehensive review

Faiyaz M, Ganayee MA, Akhtar S, Krishnan S, Flora B, Dogra D, Jha NK, Chellappan DK, Negi P, Dua K, Kesari KK, Gupta PK.

Front Biosci (Landmark Ed). 2021 Oct 30;26(10):851-865. doi: 10.52586/4992.

Artificial Chiral Interfaces against Amyloid-β Peptide Aggregation: Research Progress and Challenges

Zhou Z, Gu YQ, Wang HX.

ACS Chem Neurosci. 2021 Nov 17;12(22):4236-4248. doi: 10.1021/acschemneuro.1c00544. Epub 2021 Nov 1.

The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives

Walgrave H, Zhou L, De Strooper B, Salta E.

Mol Neurodegener. 2021 Nov 6;16(1):76. doi: 10.1186/s13024-021-00496-7.

Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion

Matthiesen ST, Rosenkjær S, Pontén M, Jensen KB, Gottrup H, Vase L.

J Alzheimers Dis. 2021;84(4):1821-1832. doi: 10.3233/JAD-210108.

An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia

Dutta S, Rahman S, Ahmad R, Kumar T, Dutta G, Banerjee S, Abubakar AR, Rowaiye AB, Dhingra S, Ravichandiran V, Kumar S, Sharma P, Haque M, Charan J.

Expert Rev Neurother. 2021 Dec;21(12):1455-1472. doi: 10.1080/14737175.2021.2003705. Epub 2021 Nov 29.

[Abdominal acupoint thread embedding therapy based on "brain-intestinal connection" for mild-to-moderate Alzheimer's disease and its effects on serum levels of APP and Aβ(1-42)]

Yang SQ, Fan DH, Yuan ZX, Su MY, Zhang ZN, Lin Y, Lin HG.

Zhongguo Zhen Jiu. 2021 Nov 12;41(11):1231-5. doi: 10.13703/j.0255-2930.20201106-k0002.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias